Institutional investors purchased a net $1.9 million shares of IMMU during the quarter ended December 2013, and now own 40.71% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CREATIVE PLANNING, INC. Bought 21.3 Thousand shares of Immunomedics Inc